Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma
- PMID: 2106751
- DOI: 10.1007/BF01605295
Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma
Abstract
Using the monoclonal antibody EGF-R1, the expression of epidermal growth factor receptor (EGFR) was investigated immunohistochemically in normal colonic mucosa distant from and adjacent to colonic neoplasms, in 25 adenomas and in 144 unselected colorectal carcinomas. EGFR expression was an inconsistent phenomenon in each of these conditions. It was not expressed in 23/44 non-neoplastic mucosa specimens distant from and in 26/44 mucosae adjacent to colon tumours; 15/25 adenomas and 71 (49.3%) of the carcinomas failed to contain detectable amounts of EGFR. In contrast, large amounts of EGFR were found in 4 non-neoplastic mucosae at both locations, in 3 adenomas and in 11 (7.6%) carcinomas. The remaining cases showed complex patterns of EGFR-expression. In comparing mucosae close to and distant from a colonic tumour, only minor differences in EGFR content were observed. The intra-individual comparison of the mode of EGFR expression in non-neoplastic and neoplastic epithelium revealed an overexpression of EGFR in carcinomas in about one third of the 44 cases examined. One third showed no obvious differences, and one third showed lower levels of EGFR expression within the tumour. We conclude that the mode of EGFR expression in normal and neoplastic colon epithelium is variable and reflective of inter-individual constitutive differences rather than of abnormalities in gene regulation. Statistical analysis failed to reveal correlations between the mode of EGFR expression and tumour grade, type or Dukes stage.
Similar articles
-
Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.J Gastrointest Cancer. 2012 Sep;43(3):444-55. doi: 10.1007/s12029-011-9330-9. J Gastrointest Cancer. 2012. PMID: 21989899
-
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.Gastroenterology. 1997 Dec;113(6):1906-15. doi: 10.1016/s0016-5085(97)70010-6. Gastroenterology. 1997. PMID: 9394730
-
Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.Am J Med Sci. 2010 Oct;340(4):296-300. doi: 10.1097/MAJ.0b013e3181e7fbf3. Am J Med Sci. 2010. PMID: 20622650
-
Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases.Histopathology. 1996 Oct;29(4):347-54. doi: 10.1111/j.1365-2559.1996.tb01418.x. Histopathology. 1996. PMID: 8910042
-
Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.Recent Results Cancer Res. 2003;162:115-32. doi: 10.1007/978-3-642-59349-9_10. Recent Results Cancer Res. 2003. PMID: 12790326 Review.
Cited by
-
The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.Curr Treat Options Oncol. 2004 Oct;5(5):393-403. doi: 10.1007/s11864-004-0029-z. Curr Treat Options Oncol. 2004. PMID: 15341677 Review.
-
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.Onco Targets Ther. 2013 Jul 24;6:967-76. doi: 10.2147/OTT.S42446. Print 2013. Onco Targets Ther. 2013. PMID: 23926437 Free PMC article.
-
Epidermal growth factor receptors in the oesophagus.Gut. 1992 Apr;33(4):439-43. doi: 10.1136/gut.33.4.439. Gut. 1992. PMID: 1582583 Free PMC article.
-
Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.Virchows Arch A Pathol Anat Histopathol. 1991;419(3):171-5. doi: 10.1007/BF01626344. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 1926758
-
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.Oncotarget. 2017 Mar 7;8(10):16507-16517. doi: 10.18632/oncotarget.14961. Oncotarget. 2017. PMID: 28157706 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous